The overactivation of CDK9 in cancer cells drives the constant production of short-lived proto-oncogenes and anti-apoptotic proteins (e.g., MYC, MCL-1, and XIAP) that are important contributors to neoplastic transformation [19,20]. Here, CDK9 is linked to cancer.